Lymphoma and Leukemia Cell Vulnerabilities and Resistance Identified by Compound Library Screens

Area of Science:

• Oncology
• Pharmacology
• Biotechnology

Background:

• Anticancer agent efficacy varies significantly among patients, necessitating identification of response factors.
• Biomarkers for drug response are essential to improve cancer treatment outcomes.
• High-throughput ex vivo drug response platforms can identify biomarkers and elucidate response mechanisms.

Purpose of the Study:

• To present a simple, scalable method for measuring anticancer drug response.
• To utilize ATP measurements as a surrogate for cell viability.
• To understand drug response variability in cancer cell lines and primary cells.

Main Methods:

• Developed a high-throughput drug screening method using ATP measurements.
• Applied the method to assess drug response in cancer cell lines.
• Applied the method to assess drug response in short-term cultures of primary cancer cells.

Main Results:

• The ATP-based assay provides a scalable measurement of cell viability after drug exposure.
• The method allows for comprehensive mapping of drug response.
• The platform facilitates the identification of biomarkers and hypotheses for drug response mechanisms.

Conclusions:

• The described method is effective for high-throughput ex vivo drug screening.
• This approach aids in understanding drug response heterogeneity in cancer.
• The platform supports biomarker discovery for personalized cancer therapy.